Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Zarowitz

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Annals of Pharmacotherapy|October 8, 1998
Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopically proven stress ulcerationJ W Devlin, T Ben-Menachem, S K Ulep, et al.
Critical Care Medicine|October 1, 1996
Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unitM I Rudis, B J Guslits, E L Peterson, et al.
Critical Care Medicine|August 14, 1999
Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unitJ W Devlin, G Boleski, M Mlynarek, et al.
DICP : the Annals of Pharmacotherapy|October 1, 1991
Monitoring serum digoxin concentrations during digoxin immune Fab therapyM R Ujhelyi, R D Colucci, D M Cummings, et al.
Annals of Internal Medicine|October 15, 1994
Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind studyT Ben-Menachem, R Fogel, R V Patel, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Critical Care Medicine|February 1, 1996
Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysisT Ben-Menachem, B D McCarthy, R Fogel, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. III. Results of initial administration. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyP H Vlasses, D R Rush, G E Dukes, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification process. I. Role delineation study. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyG E Dukes, P Gal, W A Miller, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Annals of Pharmacotherapy|October 8, 1998
Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopically proven stress ulcerationJ W Devlin, T Ben-Menachem, S K Ulep, et al.
Critical Care Medicine|October 1, 1996
Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unitM I Rudis, B J Guslits, E L Peterson, et al.
Critical Care Medicine|August 14, 1999
Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unitJ W Devlin, G Boleski, M Mlynarek, et al.
DICP : the Annals of Pharmacotherapy|October 1, 1991
Monitoring serum digoxin concentrations during digoxin immune Fab therapyM R Ujhelyi, R D Colucci, D M Cummings, et al.
Annals of Internal Medicine|October 15, 1994
Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind studyT Ben-Menachem, R Fogel, R V Patel, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Critical Care Medicine|February 1, 1996
Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysisT Ben-Menachem, B D McCarthy, R Fogel, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. III. Results of initial administration. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyP H Vlasses, D R Rush, G E Dukes, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification process. I. Role delineation study. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyG E Dukes, P Gal, W A Miller, et al.
Pageof 8